Chemotherapy is an integral part of treatment for patients with nasopharyngeal carcinoma. Chemotherapy can achieve long-term survival rates of up to 15% to 20%, even in patients with recurrent or metastatic disease. In
Daniel Chua, MB
Advertisement
Articles by Daniel Chua, MB
Advertisement
Latest Updated Articles
- Chemotherapy in Advanced Nasopharyngeal Cancer
August 1st 2000
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Ruxolitinib Tablets for Hematologic Malignancies
2
Unraveling Daraxonrasib’s Breakthrough in Metastatic Pancreatic Cancer
3
How Effective and Safe is EUS-Guided Alpha DaRT in Pancreatic Cancer?
4
Precision Medicine and the “Slow Death” of Transplant in Lymphoma
5